Wuhan Aoke Botai Biotechnology Co., Ltd

Aoke Botai develops, produces and markets monoclonal antibodies and antigens for IVD industry since 2002. ISO19001-2016/ISO9001:2015 certified company.
We are the first company in China to develop a pair of monoclonal antibodies to detect HbeAg.
Focusing on providing reagent raw materials for IVD customers, we have launched 50+ high-quality monoclonal antibody projects and 40+ high-quality antigen projects, the number continues growing ever year. The newly launched CRP project has exceeded the requirements of the industry. In Hepatitis B and secondary a... [Detail]